Understood. There have certainly been obstacles and times during the game when the home team was behind. I remain convinced as we approach the fourth quarter that Al Mann will once again win when it counts.
This article is one of the best in a while...and comes from one of the most successful investors of this decade. Thanks for posting.
There are numerous better options Al Mann could do if he felt the need. Trust this genius billionaire's 172 I.Q. and extensive experience to make the right decision. MNKD, with Afrezza and TS, is one of the highest stake games the biotech market has seen in a long time. Al Mann is working a plan that will win even though the details haven't been revealed...which makes competitive sense.
Seriously? Everyone on this MB speculates...but to address the issue, Item 1 is fact, not speculation. Item 2 is speculation based on logic that's been detailed extensively on this MB. I might decide to repeat it all again for newcomers. Item 3 is also fact as there has been zero frustration expressed from SNY or MNKD.
Exactly! There are so many clues out there but it's been difficult to put the puzzle together. One thing is for certain. Al Mann and Sanofi are playing the game at a 40,000 foot level far above retail posters and daytraders. I trust they're the ultimate experts in the global diabetes market and will win. The BIG question for all of us is when? Hoping it's sooner rather than later.
Regardless of sales to date, all of the marketing plans and dollars invested are progressing EXACTLY as determined by the 50/50 joint committee that Al required to be established for this partnership. Stop thinking SNY or MNKD are independently at fault. It's not true. There is a bigger picture with Billions at stake that is playing out exactly as SNY and MNKD together have decided. It's just that we haven't yet figured it out or been updated along the way. We should know soon whether this is a slow and methodical plan for a paradigm shift and global expansion or whether a buyout and/or restructuring agreement is forthcoming. Everyone seems to be frustrated...except SNY and MNKD, which makes the latter seem more probable.
Nice post of sanity considering all the Chicken Little posts acting as if rolling over debt and having slow scripts prior to consumer launch was horrible news. Fortunately we know better ;)
The web is spinning with negativity simply because MNKD rolled over the BOA notes and 2Q sales are growing but remain slow...prior to marketing. The important facts remain intact: 1) Diabetics using Afrezza love it, 2) Marketing has just begun with print ads coming soon, 3) The next Technosphere applications will soon be announced, 4) The SNY trial proving Afrezza is superior to other drugs concludes in January. Anyone selling now instead of buying is being DUPED by the corrupt scheming of wall street. Buy now and you will win big in the coming months.
That's a good guess but might be high to justify to SNY shareholders based on current Afrezza sales...meaning Brandicourt would have to stick his neck out pretty far to do that. One way around this would be to negotiate a package that includes both the Afrezza price and some level of ownership in MNKD technologies. For example, say SNY agrees Afrezza is worth 10B but also wants 20% ownership in MNKD Technologies. They could lower the Afrezza price to 8B and drop the ownership to 10%. Please ignore the math, I'm just guessing at a model for negotiations.
Rolling the BOA note sends a message that SNY isn't buying or even taking a 5% stake in MNKD anytime soon. If so, it would have happened now instead of rolling the note. Rolling the note does clean up MNKD's debt moving forward. Brandicourt's silence seems to hint something is in the works soon. I remain convinced SNY is going to buy Afrezza prior to: 1) the forthcoming head-to-head trial results, 2) TV ads and 3) the start of global expansion...meaning before the end of 2015.
While a third company could be involved, i.e. MDT or a giant pharma, I doubt it. SNY and Al have been working this plan together for years and know what they've got. They see the results from first adopters and already know the current trial is going to prove once and for all Afrezza's superiority. I think Brandicourt and SNY, Al and MNKD are currently silent pending the sale of Afrezza to SNY and establishing a MNKD Technology development company for Technosphere. I see SNY having a stake in that company as part of the negotiations.
Last thought is SNY and MNKD aren't concerned at all with low early scripts or the current pps knowing the forthcoming trial results will dramatically change the game for marketing, scripts and sales in 2016.
De Ja Vu...good news for MNKD and the price goes down. We've seen this movie countless times. No one "seriously" believes today's rolling over of the debt, exactly as Hakan said would happen months ago, is bad news. Regardless, the wall street hucksters, shisters and bashers flooded the streets with negative spin. Fortunately, true longs know better, picked up some cheap shares and continue to anxiously watch the shorts squirm as they run out of time. This is just downright fun to watch!
Bump the good post. All who follow MNKD know the action today and AF's article is a final attempt to trick novices into selling. This is about to turn quickly.
This is a bizarre perspective thinking an AF article will have any effect slowing down the success of Afrezza...but nice try
Traders worry about daily or weekly announcements whereas Sanofi is following a business model to gradually introduce a new, global, paradigm shifting drug. Sanofi just began DTC print ads this month. This will be followed by TV ads toward the end of the year when Sanofi finalizes the head-to-head trial proving Afreeza's clear superiority over ALL prandial insulins. It's far, far too early to worry about anything at this early stage. As to a buyout or restructuring, NO ONE knows except Al and Sanofi. It could happen any day or possibly months from now. Regardless, the announcement will come as a total surprise without advance notice.
Just thought it timely to point out the obvious...not to mention it's about the 20th short argument in a row that has now died.
Must be embarassing to have this incorrect post and no credibility. It's noted the title doesn't reference anything about an online version.